Moreover, the KRAS gene is not only one of the most critical mutated genes in CRC (5), but also deeply involved in the signal transduction of EGFR, influencing the clinical course of CRC across multiple dimensions including pathogenesis, progression, clinical treatment, and patient prognosis (6). Here, KRAS is linked to colorectal carcinoma.